We've spent hundreds of hours testing treadmills — these are the best

From top tier, gamified options to reliable 'mills that monitor your progress with pace, hills, and distance, these are the ...

KEYTRUDA® (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...

Cantor Equity Partners III Inc. Cl A

Cantor Equity Partners III Inc. Cl A detailed financials by Barron's. View CAEP business summary and company performance, for a clear financial breakdown.